Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04536077
Status:
TERMINATED
Last Update Posted:
2024-02-20
First Post:
2020-08-27
Brief Title:
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Organization Data
Organization:
Washington University School of Medicine
Class:
OTHER
Study ID:
202011125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Washington University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Celldex Therapeutics | INDUSTRY |
| The Foundation for Barnes-Jewish Hospital | OTHER |